1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015

Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015" provides an overview of Post-Myocardial Infarction clinical trials scenario. This report provides top line data relating to the clinical trials on Post-Myocardial Infarction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Post-Myocardial Infarction to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Post-Myocardial Infarction to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Post-Myocardial Infarction Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 45
Abbreviations 45
Definitions 45
Research Methodology 46
Secondary Research 46
About GlobalData 47
Contact Us 47
Disclaimer 47
Source 48

List of Tables
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials by Region, 2015* 6
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Post-Myocardial Infarction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Post-Myocardial Infarction Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Post-Myocardial Infarction Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Post-Myocardial Infarction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Post-Myocardial Infarction to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14
Post-Myocardial Infarction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Post-Myocardial Infarction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Post-Myocardial Infarction to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17
Post-Myocardial Infarction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Post-Myocardial Infarction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Post-Myocardial Infarction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Post-Myocardial Infarction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Post-Myocardial Infarction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Post-Myocardial Infarction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Post-Myocardial Infarction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Post-Myocardial Infarction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

List of Figures
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Post-Myocardial Infarction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Post-Myocardial Infarction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Post-Myocardial Infarction Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Post-Myocardial Infarction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Post-Myocardial Infarction to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14
Post-Myocardial Infarction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Post-Myocardial Infarction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Post-Myocardial Infarction to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17
Post-Myocardial Infarction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Post-Myocardial Infarction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Post-Myocardial Infarction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Post-Myocardial Infarction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Post-Myocardial Infarction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Post-Myocardial Infarction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Post-Myocardial Infarction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Post-Myocardial Infarction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Post-Myocardial Infarction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 46

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Myocardial Infarction  - Market Insights, Epidemiology and Market Forecast-2023

Myocardial Infarction  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Myocardial Infarction - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Myocardial Infarction fo ...

Myocardial Infarction  - Epidemiology Forecast To 2023

Myocardial Infarction  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Myocardial Infarction  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Myocardial Infarction  in seven major markets (US, France, Germany, Italy, ...

Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.